ZA9530B - Compositions for use in treating neurogenic inflammation - Google Patents

Compositions for use in treating neurogenic inflammation

Info

Publication number
ZA9530B
ZA9530B ZA9530A ZA9530A ZA9530B ZA 9530 B ZA9530 B ZA 9530B ZA 9530 A ZA9530 A ZA 9530A ZA 9530 A ZA9530 A ZA 9530A ZA 9530 B ZA9530 B ZA 9530B
Authority
ZA
South Africa
Prior art keywords
compositions
neurogenic inflammation
treating neurogenic
treating
inflammation
Prior art date
Application number
ZA9530A
Other languages
English (en)
Inventor
Knud Erik Andersen
Uffe Bang Olsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA9530B publication Critical patent/ZA9530B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9530A 1994-01-04 1995-01-04 Compositions for use in treating neurogenic inflammation ZA9530B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK2094 1994-01-04

Publications (1)

Publication Number Publication Date
ZA9530B true ZA9530B (en) 1996-07-04

Family

ID=8088844

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9530A ZA9530B (en) 1994-01-04 1995-01-04 Compositions for use in treating neurogenic inflammation

Country Status (13)

Country Link
EP (1) EP0735872A1 (fr)
JP (1) JPH09507849A (fr)
CN (1) CN1142183A (fr)
AU (1) AU1311195A (fr)
BR (1) BR9506453A (fr)
CA (1) CA2180239A1 (fr)
CZ (1) CZ198396A3 (fr)
FI (1) FI962750A (fr)
HU (1) HUT76281A (fr)
IL (1) IL112223A0 (fr)
NO (1) NO962812L (fr)
WO (1) WO1995018615A1 (fr)
ZA (1) ZA9530B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022342A1 (fr) * 1995-12-15 1997-06-26 Novo Nordisk A/S Nouveau procede
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965639A (en) * 1960-12-20 New basically substituted azepine
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer

Also Published As

Publication number Publication date
FI962750A0 (fi) 1996-07-04
CN1142183A (zh) 1997-02-05
WO1995018615A1 (fr) 1995-07-13
EP0735872A1 (fr) 1996-10-09
FI962750A (fi) 1996-09-04
AU1311195A (en) 1995-08-01
CA2180239A1 (fr) 1995-07-13
IL112223A0 (en) 1995-03-30
HUT76281A (en) 1997-07-28
NO962812L (no) 1996-09-04
HU9601826D0 (en) 1996-09-30
NO962812D0 (no) 1996-07-03
CZ198396A3 (en) 1997-01-15
JPH09507849A (ja) 1997-08-12
BR9506453A (pt) 1997-09-02

Similar Documents

Publication Publication Date Title
EG20753A (en) Synergistic composition
IL115891A0 (en) Hemorrhoidial compositions and their use
IL112921A0 (en) Methods and compositions for inhibiting cell proliferative disorders
IL115693A0 (en) Cosmetic composition
GB9423952D0 (en) Cleaning compositions and their use
GB9414721D0 (en) Dentifrice composition
HK1033653A1 (en) Synergistic composition and use thereof
IL115766A0 (en) Composition and treatment for multiple sclerosis
ZA9510181B (en) Cosmetic composition
HU9501088D0 (en) Improvements in general purpose cleaning compositions
ZA974266B (en) Anti-vaginitis compositions for topical use
ZA914102B (en) Methods for treating inflammation and compounds and compositions suitable for use therein
GB9607963D0 (en) Cleansing composition
IL113661A0 (en) Compositions and treatment for multiple sclerosis
GB9422098D0 (en) Cosmetic composition
IL111554A (en) Methods and compositions for hair treatment
GB9423234D0 (en) Cleaning compositions and their use
IL129446A0 (en) Compositions for use in concrete and concrete products obtained therefrom
EP0835092A4 (fr) Composition et traitement pour la lutte contre la calvitie
GB9420616D0 (en) Method, compositions and use
GB9415623D0 (en) Improvements in oleaginous compositions
ZA9530B (en) Compositions for use in treating neurogenic inflammation
GB9415061D0 (en) Improvements in or relating to mixers for ablutionary installations
GB9422099D0 (en) Cosmetic composition
IL113444A0 (en) Compositions and methods for treating leukemia